Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
Boston Medical Center, MA, USA. gwilkes@comcast.net
Gail
G
Wilkes
D000707:Anaphylaxis / Q000139:chemically induced* / Q000175:diagnosis / Q000451:nursing; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001249:Asthma / Q000150:complications; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000451:nursing; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology* / Q000451:nursing; D016903:Drug Monitoring / Q000451:nursing; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D024802:Nurse's Role; D009730:Nursing Assessment; D009859:Oncology Nursing / Q000458:organization & administration*; D010353:Patient Education as Topic
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab